Precision Virologics

company

About

Precision Virologics is a St. Louis-based biotech startup.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$215.08K
Industries
Biotechnology,Commercial,Health Care,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$515.08K
Precision Virologics has raised a total of $515.08K in funding over 2 rounds. Their latest funding was raised on Mar 20, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 20, 2019 Grant $300K 1 National Institutes of Health Detail
Sep 18, 2018 Grant $215.08K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Precision Virologics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant